Palo Alto Investors’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-5,049
Closed -$58K 39
2019
Q2
$58K Hold
5,049
﹤0.01% 39
2019
Q1
$35K Hold
5,049
﹤0.01% 37
2018
Q4
$27K Hold
5,049
﹤0.01% 36
2018
Q3
$165K Hold
5,049
0.01% 36
2018
Q2
$757K Hold
5,049
0.03% 33
2018
Q1
$833K Hold
5,049
0.04% 33
2017
Q4
$621K Hold
5,049
0.03% 35
2017
Q3
$600K Hold
5,049
0.03% 37
2017
Q2
$542K Hold
5,049
0.03% 35
2017
Q1
$524K Hold
5,049
0.02% 36
2016
Q4
$506K Sell
5,049
-2,527
-33% -$351K 0.03% 36
2016
Q3
$1.46M Hold
7,576
0.08% 34
2016
Q2
$777K Hold
7,576
0.06% 41
2016
Q1
$1.04M Hold
7,576
0.08% 37
2015
Q4
$1.59M Hold
7,576
0.09% 37
2015
Q3
$1.81M Hold
7,576
0.09% 37
2015
Q2
$2.94M Hold
7,576
0.13% 35
2015
Q1
$4.54M Hold
7,576
0.22% 35
2014
Q4
$5M Buy
+7,576
New +$5M 0.29% 37

Other funds holding OCGN

Palo Alto Investors's OCGN Position: Q3 2019 in Review

Palo Alto Investors sold out of Ocugen (OCGN) in Q3 2019, closing a stake of 5,049 shares — an estimated $58K sold.

Palo Alto Investors first reported a position in OCGN in Q4 2014 and held it in 19 quarters. The position peaked at $5M in Q4 2014. 14 funds tracked by Wall St. Rank hold OCGN as of Q3 2019.

  • Palo Alto Investors reported no remaining Ocugen position as of Q3 2019 after selling out during the quarter.
  • Palo Alto Investors sold 5,049 Ocugen shares in Q3 2019, an estimated $58K.
  • Palo Alto Investors first reported a position in Ocugen in Q4 2014 and held it in 19 quarters.
  • Palo Alto Investors's Ocugen position peaked at $5M in Q4 2014.
  • 14 funds tracked by Wall St. Rank held Ocugen as of Q3 2019.

Based on Palo Alto Investors's 13F filing for Q3 2019, filed 14 Nov 2019.